This old heart: Cardiac aging and autophagy

Journal of Molecular and Cellular Cardiology

Volumn 83, Issue , 2015, Pages 44-54

  Linton, Phyllis Jean ^a   Gurney, Michael ^a   Sengstock, David ^b,d   Mentzer, Robert M ^c   Gottlieb, Roberta A ^c  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b OAKWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Aging; Autophagy; Cardiac; Human studies; Inflammation

Indexed keywords

ADENOSINE TRIPHOSPHATE; BECLIN 1; CELL PROTEIN; CRYOPYRIN; HEAT SHOCK PROTEIN 90; INTERLEUKIN 1BETA; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2A; MAMMALIAN TARGET OF RAPAMYCIN; MITOCHONDRIAL DNA; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; SIRTUIN 1; TOLL LIKE RECEPTOR; ULK1 PROTEIN; UNCLASSIFIED DRUG; MAP1LC3A PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; PARKIN; PROTEIN KINASE; PTEN-INDUCED PUTATIVE KINASE; UBIQUITIN PROTEIN LIGASE;

AGING; ATRIAL FIBRILLATION; AUTOPHAGY; CARDIOPULMONARY BYPASS; CARDITIS; CELL REGENERATION; CELLULAR STRESS RESPONSE; CHAPERONE-MEDIATED AUTOPHAGY; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY BYPASS SURGERY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFECT; HEART ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION PREVENTION; HEART MITOCHONDRION; HEART MUSCLE BIOPSY; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HOMEOSTATIC INTRACELLULAR REPAIR RESPONSE; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; LONGEVITY; LYSOSOME; NONHUMAN; POLYMERASE CHAIN REACTION; POSTOPERATIVE ATRIAL FIBRILLATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN METABOLISM; REVIEW; UBIQUITINATION; WESTERN BLOTTING; ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; GENE EXPRESSION REGULATION; GENETICS; HOMEOSTASIS; METABOLISM; MITOCHONDRION; PATHOLOGY; SIGNAL TRANSDUCTION;

AGING; ANIMALS; ARRHYTHMIAS, CARDIAC; AUTOPHAGY; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; LONGEVITY; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIA; MYOCARDIUM; MYOCYTES, CARDIAC; PROTEIN KINASES; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 84937970106     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.12.017     Document Type: Review

References (161)

1. Kroemer G., Marino G., Levine B. Autophagy and the integrated stress response. Mol Cell 2010, 40:280-293.
2. Ren S.Y., Xu X. Role of autophagy in metabolic syndrome-associated heart disease. Biochim Biophys Acta 2015, 1852:225-231.
3. Tanaka K., Matsuda N. Proteostasis and neurodegeneration: the roles of proteasomal degradation and autophagy. Biochim Biophys Acta 1843, 2014:197-204.
4. Malicdan M.C., Noguchi S., Nishino I. Monitoring autophagy in muscle diseases. Methods Enzymol 2009, 453:379-396.
5. Yang Z.J., Chee C.E., Huang S., Sinicrope F.A. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 2011, 10:1533-1541.
6. Mathew R., Karantza-Wadsworth V., White E. Role of autophagy in cancer. Nat Rev Cancer 2007, 7:961-967.
7. De Meyer G.R., Martinet W. Autophagy in the cardiovascular system. Biochim Biophys Acta 2009, 1793:1485-1495.
8. Quan W., Lee M.S. Role of autophagy in the control of body metabolism. Endocrinol Metab 2013, 28:6-11.
9. Deretic V., Saitoh T., Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol 2013, 13:722-737.
10. Yuk J.M., Yoshimori T., Jo E.K. Autophagy and bacterial infectious diseases. Exp Mol Med 2012, 44:99-108.
11. Kudchodkar S.B., Levine B. Viruses and autophagy. Rev Med Virol 2009, 19:359-378.
12. Schneider J.L., Cuervo A.M. Autophagy and human disease: emerging themes. Curr Opin Genet Dev 2014, 26C:16-23.
13. Li W.W., Li J., Bao J.K. Microautophagy: lesser-known self-eating. Cell Mol Life Sci 2012, 69:1125-1136.
14. Mijaljica D., Prescott M., Devenish R.J. Different fates of mitochondria: alternative ways for degradation?. Autophagy 2007, 3:4-9.
15. de Waal E.J., Vreeling-Sindelarova H., Schellens J.P., James J. Starvation-induced microautophagic vacuoles in rat myocardial cells. Cell Biol Int Rep 1986, 10:527-533.
16. Takikita S., Myerowitz R., Zaal K., Raben N., Plotz P.H. Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches. Mol Genet Metab 2009, 96:208-217.
17. Dice J.F., Terlecky S.R., Chiang H.L., Olson T.S., Isenman L.D., Short-Russell S.R., et al. A selective pathway for degradation of cytosolic proteins by lysosomes. Semin Cell Biol 1990, 1:449-455.
18. Bandyopadhyay U., Kaushik S., Varticovski L., Cuervo A.M. The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane. Mol Cell Biol 2008, 28:5747-5763.
19. Aniento F., Roche E., Cuervo A.M., Knecht E. Uptake and degradation of glyceraldehyde-3-phosphate dehydrogenase by rat liver lysosomes. J Biol Chem 1993, 268:10463-10470.
20. Kiffin R., Christian C., Knecht E., Cuervo A.M. Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell 2004, 15:4829-4840.
21. Cuervo A.M., Dice J.F. Age-related decline in chaperone-mediated autophagy. J Biol Chem 2000, 275:31505-31513.
22. Kiffin R., Kaushik S., Zeng M., Bandyopadhyay U., Zhang C., Massey A.C., et al. Altered dynamics of the lysosomal receptor for chaperone-mediated autophagy with age. J Cell Sci 2007, 120:782-791.
23. Zhang C., Cuervo A.M. Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function. Nat Med 2008, 14:959-965.
24. Takemura G., Kanamori H., Goto K., Maruyama R., Tsujimoto A., Fujiwara H., et al. Autophagy maintains cardiac function in the starved adult. Autophagy 2009, 5:1034-1036.
25. Gustafsson A.B., Gottlieb R.A. Autophagy in ischemic heart disease. Circ Res 2009, 104:150-158.
26. Reggiori F., Komatsu M., Finley K., Simonsen A. Selective types of autophagy. Int J Cell Biol 2012, 2012:156272.
27. He C., Klionsky D.J. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 2009, 43:67-93.
28. Ravikumar B., Sarkar S., Davies J.E., Futter M., Garcia-Arencibia M., Green-Thompson Z.W., et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 2010, 90:1383-1435.
29. Baek K.H., Park J., Shin I. Autophagy-regulating small molecules and their therapeutic applications. Chem Soc Rev 2012, 41:3245-3263.
30. Mizushima N., Yoshimori T., Ohsumi Y. The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol 2011, 27:107-132.
31. Shanware N.P., Bray K., Abraham R.T. The PI3K, metabolic, and autophagy networks: interactive partners in cellular health and disease. Annu Rev Pharmacol Toxicol 2013, 53:89-106.
32. Axe E.L., Walker S.A., Manifava M., Chandra P., Roderick H.L., Habermann A., et al. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J Cell Biol 2008, 182:685-701.
33. Hayashi-Nishino M., Fujita N., Noda T., Yamaguchi A., Yoshimori T., Yamamoto A. A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation. Nat Cell Biol 2009, 11:1433-1437.
34. Yla-Anttila P., Vihinen H., Jokitalo E., Eskelinen E.L. 3D tomography reveals connections between the phagophore and endoplasmic reticulum. Autophagy 2009, 5:1180-1185.
35. Hailey D.W., Rambold A.S., Satpute-Krishnan P., Mitra K., Sougrat R., Kim P.K., et al. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell 2010, 141:656-667.
36. Ravikumar B., Moreau K., Jahreiss L., Puri C., Rubinsztein D.C. Plasma membrane contributes to the formation of pre-autophagosomal structures. Nat Cell Biol 2010, 12:747-757.
37. Otomo C., Metlagel Z., Takaesu G., Otomo T. Structure of the human ATG12-ATG5 conjugate required for LC3 lipidation in autophagy. Nat Struct Mol Biol 2013, 20:59-66.
38. Tooze S.A., Yoshimori T. The origin of the autophagosomal membrane. Nat Cell Biol 2010, 12:831-835.
39. Bartlett B.J., Isakson P., Lewerenz J., Sanchez H., Kotzebue R.W., Cumming R.C., et al. p62, Ref(2)P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects. Autophagy 2011, 7:572-583.
40. Clausen T.H., Lamark T., Isakson P., Finley K., Larsen K.B., Brech A., et al. p62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy. Autophagy 2010, 6:330-344.
41. Geisler S., Holmstrom K.M., Skujat D., Fiesel F.C., Rothfuss O.C., Kahle P.J., et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 2010, 12:119-131.
42. Narendra D., Tanaka A., Suen D.F., Youle R.J. Parkin-induced mitophagy in the pathogenesis of Parkinson disease. Autophagy 2009, 5:706-708.
43. Li W., Bengtson M.H., Ulbrich A., Matsuda A., Reddy V.A., Orth A., et al. Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling. PLoS One 2008, 3:e1487.
44. Simonsen A., Cumming R.C., Brech A., Isakson P., Schubert D.R., Finley K.D. Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila. Autophagy 2008, 4:176-184.
45. Pyo J.O., Yoo S.M., Ahn H.H., Nah J., Hong S.H., Kam T.I., et al. Overexpression of Atg5 in mice activates autophagy and extends lifespan. Nat Commun 2013, 4:2300.
46. Madeo F., Tavernarakis N., Kroemer G. Can autophagy promote longevity?. Nat Cell Biol 2010, 12:842-846.
47. Kaeberlein M., Burtner C.R., Kennedy B.K. Recent developments in yeast aging. PLoS Genet 2007, 3:e84.
48. Harrison D.E., Strong R., Sharp Z.D., Nelson J.F., Astle C.M., Flurkey K., et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460:392-395.
49. Speakman J.R., Mitchell S.E. Caloric restriction. Mol Aspects Med 2011, 32:159-221.
50. Morselli E., Maiuri M.C., Markaki M., Megalou E., Pasparaki A., Palikaras K., et al. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis 2010, 1:e10.
51. Bjedov I., Toivonen J.M., Kerr F., Slack C., Jacobson J., Foley A., et al. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab 2010, 11:35-46.
52. Alvers A.L., Wood M.S., Hu D., Kaywell A.C., Dunn W.A., Aris J.P. Autophagy is required for extension of yeast chronological life span by rapamycin. Autophagy 2009, 5:847-849.
53. Lee I.H., Cao L., Mostoslavsky R., Lombard D.B., Liu J., Bruns N.E., et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci U S A 2008, 105:3374-3379.
54. Harman D. The biologic clock: the mitochondria?. J Am Geriatr Soc 1972, 20:145-147.
55. Dai D.F., Chiao Y.A., Marcinek D.J., Szeto H.H., Rabinovitch P.S. Mitochondrial oxidative stress in aging and healthspan. Longev Healthspan 2014, 3:6.
56. Bergmann O., Bhardwaj R.D., Bernard S., Zdunek S., Barnabe-Heider F., Walsh S., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
57. Rezzani R., Stacchiotti A., Rodella L.F. Morphological and biochemical studies on aging and autophagy. Ageing Res Rev 2012, 11:10-31.
58. Judge S., Jang Y.M., Smith A., Hagen T., Leeuwenburgh C. Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging. FASEB J 2005, 19:419-421.
59. Mammucari C., Rizzuto R. Signaling pathways in mitochondrial dysfunction and aging. Mech Ageing Dev 2010, 131:536-543.
60. Mammucari C., Milan G., Romanello V., Masiero E., Rudolf R., Del Piccolo P., et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 2007, 6:458-471.
61. Terman A., Brunk U.T. Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res 2005, 68:355-365.
62. Terman A., Kurz T., Navratil M., Arriaga E.A., Brunk U.T. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid Redox Signal 2010, 12:503-535.
63. Misra M.K., Sarwat M., Bhakuni P., Tuteja R., Tuteja N. Oxidative stress and ischemic myocardial syndromes. Med Sci Monit 2009, 15:RA209-RA219.
64. Li L., Chen Y., Gibson S.B. Starvation-induced autophagy is regulated by mitochondrial reactive oxygen species leading to AMPK activation. Cell Signal 2013, 25:50-65.
65. Scherz-Shouval R., Shvets E., Fass E., Shorer H., Gil L., Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 2007, 26:1749-1760.
66. Taneike M., Yamaguchi O., Nakai A., Hikoso S., Takeda T., Mizote I., et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy 2010, 6:600-606.
67. Martinez-Vicente M., Sovak G., Cuervo A.M. Protein degradation and aging. Exp Gerontol 2005, 40:622-633.
68. Brunk U.T., Jones C.B., Sohal R.S. A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis. Mutat Res 1992, 275:395-403.
69. Gottlieb R.A., Carreira R.S. Autophagy in health and disease. 5. Mitophagy as a way of life. Am J Physiol Cell Physiol 2010, 299:C203-C210.
70. Rajawat Y.S., Hilioti Z., Bossis I. Aging: central role for autophagy and the lysosomal degradative system. Ageing Res Rev 2009, 8:199-213.
71. Wohlgemuth S.E., Julian D., Akin D.E., Fried J., Toscano K., Leeuwenburgh C., et al. Autophagy in the heart and liver during normal aging and calorie restriction. Rejuvenation Res 2007, 10:281-292.
72. Boyle A.J., Shih H., Hwang J., Ye J., Lee B., Zhang Y., et al. Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy. Exp Gerontol 2011, 46:549-559.
73. Uddin M.N., Nishio N., Ito S., Suzuki H., Isobe K. Autophagic activity in thymus and liver during aging. Age (Dordr) 2012, 34:75-85.
74. Inuzuka Y., Okuda J., Kawashima T., Kato T., Niizuma S., Tamaki Y., et al. Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice. Circulation 2009, 120:1695-1703.
75. Vittorini S., Paradiso C., Donati A., Cavallini G., Masini M., Gori Z., et al. The age-related accumulation of protein carbonyl in rat liver correlates with the age-related decline in liver proteolytic activities. J Gerontol A Biol Sci Med Sci 1999, 54:B318-B323.
76. Klionsky D.J., Abdalla F.C., Abeliovich H., Abraham R.T., Acevedo-Arozena A., Adeli K., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8:445-544.
77. Karamanlidis G., Bautista-Hernandez V., Fynn-Thompson F., del Nido P., Tian R. Impaired mitochondrial biogenesis precedes heart failure in right ventricular hypertrophy in congenital heart disease. Circ Heart Fail 2011, 4:707-713.
78. Hoshino A., Mita Y., Okawa Y., Ariyoshi M., Iwai-Kanai E., Ueyama T., et al. Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart. Nat Commun 2013, 4:2308.
79. Kubli D.A., Quinsay M.N., Gustafsson A.B. Parkin deficiency results in accumulation of abnormal mitochondria in aging myocytes. Commun Integr Biol 2013, 6:e24511.
80. Mariathasan S., Weiss D.S., Newton K., McBride J., O'Rourke K., Roose-Girma M., et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440:228-232.
81. Duewell P., Kono H., Rayner K.J., Sirois C.M., Vladimer G., Bauernfeind F.G., et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464:1357-1361.
82. Rajamaki K., Lappalainen J., Oorni K., Valimaki E., Matikainen S., Kovanen P.T., et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One 2010, 5:e11765.
83. Yamasaki K., Muto J., Taylor K.R., Cogen A.L., Audish D., Bertin J., et al. NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem 2009, 284:12762-12771.
84. Pazar B., Ea H.K., Narayan S., Kolly L., Bagnoud N., Chobaz V., et al. Basic calcium phosphate crystals induce monocyte/macrophage IL-1beta secretion through the NLRP3 inflammasome in vitro. J Immunol 2011, 186:2495-2502.
85. Halle A., Hornung V., Petzold G.C., Stewart C.R., Monks B.G., Reinheckel T., et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 2008, 9:857-865.
86. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
87. Perregaux D., Gabel C.A. Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem 1994, 269:15195-15203.
88. + release. Am J Physiol Cell Physiol 2004, 286:C1100-C1108.
89. Kanneganti T.D., Lamkanfi M., Kim Y.G., Chen G., Park J.H., Franchi L., et al. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 2007, 26:433-443.
90. Hornung V., Bauernfeind F., Halle A., Samstad E.O., Kono H., Rock K.L., et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008, 9:847-856.
91. Fubini B., Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic Biol Med 2003, 34:1507-1516.
92. Cruz C.M., Rinna A., Forman H.J., Ventura A.L., Persechini P.M., Ojcius D.M. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem 2007, 282:2871-2879.
93. Levine B., Mizushima N., Virgin H.W. Autophagy in immunity and inflammation. Nature 2011, 469:323-335.
94. Nakahira K., Haspel J.A., Rathinam V.A., Lee S.J., Dolinay T., Lam H.C., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011, 12:222-230.
95. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
96. Shimada K., Crother T.R., Karlin J., Dagvadorj J., Chiba N., Chen S., et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012, 36:401-414.
97. Bergsbaken T., Fink S.L., Cookson B.T. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 2009, 7:99-109.
98. Harris J., Hartman M., Roche C., Zeng S.G., O'Shea A., Sharp F.A., et al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem 2011, 286:9587-9597.
99. Saitoh T., Fujita N., Jang M.H., Uematsu S., Yang B.G., Satoh T., et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008, 456:264-268.
100. Shi C.S., Shenderov K., Huang N.N., Kabat J., Abu-Asab M., Fitzgerald K.A., et al. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 2012, 13:255-263.
101. Youm Y.H., Grant R.W., McCabe L.R., Albarado D.C., Nguyen K.Y., Ravussin A., et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab 2013, 18:519-532.
102. Marchant D.J., Boyd J.H., Lin D.C., Granville D.J., Garmaroudi F.S., McManus B.M. Inflammation in myocardial diseases. Circ Res 2012, 110:126-144.
103. Yellon D.M., Hausenloy D.J. Myocardial reperfusion injury. N Engl J Med 2007, 357:1121-1135.
104. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res 2002, 53:31-47.
105. Hwang M.W., Matsumori A., Furukawa Y., Ono K., Okada M., Iwasaki A., et al. Neutralization of interleukin-1beta in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling. J Am Coll Cardiol 2001, 38:1546-1553.
106. Abbate A., Salloum F.N., Vecile E., Das A., Hoke N.N., Straino S., et al. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation 2008, 117:2670-2683.
107. Kawaguchi M., Takahashi M., Hata T., Kashima Y., Usui F., Morimoto H., et al. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 2011, 123:594-604.
108. Mezzaroma E., Toldo S., Farkas D., Seropian I.M., Van Tassell B.W., Salloum F.N., et al. The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci U S A 2011, 108:19725-19730.
109. Sandanger O., Ranheim T., Vinge L.E., Bliksoen M., Alfsnes K., Finsen A.V., et al. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovasc Res 2013, 99:164-174.
110. Zuurbier C.J., Jong W.M., Eerbeek O., Koeman A., Pulskens W.P., Butter L.M., et al. Deletion of the innate immune NLRP3 receptor abolishes cardiac ischemic preconditioning and is associated with decreased Il-6/STAT3 signaling. PLoS One 2012, 7:e40643.
111. Takahashi M. NLRP3 inflammasome as a novel player in myocardial infarction. Int Heart J 2014, 55:101-105.
112. Jong W.M., Zuurbier C.J. A role for NLRP3 inflammasome in acute myocardial ischaemia-reperfusion injury?. Cardiovasc Res 2013, 99:226.
113. Riehle C., Abel E.D. Insulin regulation of myocardial autophagy. Circ J 2014, 78:2569-2576.
114. Kassiotis C., Ballal K., Wellnitz K., Vela D., Gong M., Salazar R., et al. Markers of autophagy are downregulated in failing human heart after mechanical unloading. Circulation 2009, 120:S191-S197.
115. Garcia L., Verdejo H.E., Kuzmicic J., Zalaquett R., Gonzalez S., Lavandero S., et al. Impaired cardiac autophagy in patients developing postoperative atrial fibrillation. J Thorac Cardiovasc Surg 2012, 143:451-459.
116. Jahania S.M., Sengstock D., Vaitkevicius P., Andres A., Ito B.R., Gottlieb R.A., et al. Activation of the homeostatic intracellular repair response during cardiac surgery. J Am Coll Surg 2013, 216:719-726. [discussion 26-9].
117. Singh K.K., Yanagawa B., Quan A., Wang R., Garg A., Khan R., et al. Autophagy gene fingerprint in human ischemia and reperfusion. J Thorac Cardiovasc Surg 2014, 147:1065-72.e1.
118. Gedik N., Thielmann M., Kottenberg E., Peters J., Jakob H., Heusch G., et al. No evidence for activated autophagy in left ventricular myocardium at early reperfusion with protection by remote ischemic preconditioning in patients undergoing coronary artery bypass grafting. PLoS One 2014, 9:e96567.
119. Rubinsztein D.C., Marino G., Kroemer G. Autophagy and aging. Cell 2011, 146:682-695.
120. Salminen A., Kaarniranta K. SIRT1: regulation of longevity via autophagy. Cell Signal 2009, 21:1356-1360.
121. Eisenberg T., Knauer H., Schauer A., Buttner S., Ruckenstuhl C., Carmona-Gutierrez D., et al. Induction of autophagy by spermidine promotes longevity. Nat Cell Biol 2009, 11:1305-1314.
122. Cox L.S., Mattison J.A. Increasing longevity through caloric restriction or rapamycin feeding in mammals: common mechanisms for common outcomes?. Aging Cell 2009, 8:607-613.
123. Gomez T.A., Clarke S.G. Autophagy and insulin/TOR signaling in Caenorhabditis elegans pcm-1 protein repair mutants. Autophagy 2007, 3:357-359.
124. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
125. 2) is increased in older adults and is upregulated by ischemia. J Am Geriatr Soc 2014, 62:S108.
126. Giricz Z., Mentzer R.M., Gottlieb R.A. Autophagy, myocardial protection, and the metabolic syndrome. J Cardiovasc Pharmacol 2012, 60:125-132.
127. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136.
128. Zhao Z.Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.P., Guyton R.A., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003, 285:H579-H588.
129. Han Z., Cao J., Song D., Tian L., Chen K., Wang Y., et al. Autophagy is involved in the cardioprotection effect of remote limb ischemic postconditioning on myocardial ischemia/reperfusion injury in normal mice, but not diabetic mice. PLoS One 2014, 9:e86838.
130. Huang C., Yitzhaki S., Perry C.N., Liu W., Giricz Z., Mentzer R.M., et al. Autophagy induced by ischemic preconditioning is essential for cardioprotection. J Cardiovasc Transl Res 2010, 3:365-373.
131. Wei C., Li H., Han L., Zhang L., Yang X. Activation of autophagy in ischemic postconditioning contributes to cardioprotective effects against ischemia/reperfusion injury in rat hearts. J Cardiovasc Pharmacol 2013, 61:416-422.
132. Huang C., Andres A.M., Ratliff E.P., Hernandez G., Lee P., Gottlieb R.A. Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS One 2011, 6:e20975.
133. Sala-Mercado J.A., Wider J., Undyala V.V., Jahania S., Yoo W., Mentzer R.M., et al. Profound cardioprotection with chloramphenicol succinate in the swine model of myocardial ischemia-reperfusion injury. Circulation 2010, 122:S179-S184.
134. Shinmura K., Tamaki K., Sano M., Murata M., Yamakawa H., Ishida H., et al. Impact of long-term caloric restriction on cardiac senescence: caloric restriction ameliorates cardiac diastolic dysfunction associated with aging. J Mol Cell Cardiol 2011, 50:117-127.
135. Andres A.M., Hernandez G., Lee P., Huang C., Ratliff E.P., Sin J., et al. Mitophagy is required for acute cardioprotection by simvastatin. Antioxid Redox Signal 2014, 21:1960-1973.
136. Xie M., Kong Y., Tan W., May H., Battiprolu P.K., Pedrozo Z., et al. Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. Circulation 2014, 129:1139-1151.
137. Dutta D., Xu J., Kim J.S., Dunn W.A., Leeuwenburgh C. Upregulated autophagy protects cardiomyocytes from oxidative stress-induced toxicity. Autophagy 2013, 9:328-344.
138. Yan L., Vatner D.E., Kim S.J., Ge H., Masurekar M., Massover W.H., et al. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci U S A 2005, 102:13807-13812.
139. Matsui Y., Takagi H., Qu X., Abdellatif M., Sakoda H., Asano T., et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007, 100:914-922.
140. Matsunaga K., Saitoh T., Tabata K., Omori H., Satoh T., Kurotori N., et al. Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat Cell Biol 2009, 11:385-396.
141. Ma X., Liu H., Foyil S.R., Godar R.J., Weinheimer C.J., Hill J.A., et al. Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia-reperfusion injury. Circulation 2012, 125:3170-3181.
142. Kubli D.A., Zhang X., Lee Y., Hanna R.A., Quinsay M.N., Nguyen C.K., et al. Parkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarction. J Biol Chem 2013, 288:915-926.
143. Siddall H.K., Yellon D.M., Ong S.B., Mukherjee U.A., Burke N., Hall A.R., et al. Loss of PINK1 increases the heart's vulnerability to ischemia-reperfusion injury. PLoS One 2013, 8:e62400.
144. Nakai A., Yamaguchi O., Takeda T., Higuchi Y., Hikoso S., Taniike M., et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 2007, 13:619-624.
145. Bhuiyan M.S., Pattison J.S., Osinska H., James J., Gulick J., McLendon P.M., et al. Enhanced autophagy ameliorates cardiac proteinopathy. J Clin Invest 2013, 123:5284-5297.
146. Zhu H., Tannous P., Johnstone J.L., Kong Y., Shelton J.M., Richardson J.A., et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest 2007, 117:1782-1793.
147. Sciarretta S., Volpe M., Sadoshima J. Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ Res 2014, 114:549-564.
148. Kobayashi S., Liang Q. Autophagy and mitophagy in diabetic cardiomyopathy. Biochim Biophys Acta 2015, 1852:252-261.
149. Essop M.F., Anna Chan W.Y., Valle A., Garcia-Palmer F.J., Du Toit E.F. Impaired contractile function and mitochondrial respiratory capacity in response to oxygen deprivation in a rat model of pre-diabetes. Acta Physiol 2009, 197:289-296.
150. Yu L., Fink B.D., Herlein J.A., Oltman C.L., Lamping K.G., Sivitz W.I. Dietary fat, fatty acid saturation and mitochondrial bioenergetics. J Bioenerg Biomembr 2014, 46:33-44.
151. Chess D.J., Stanley W.C. Role of diet and fuel overabundance in the development and progression of heart failure. Cardiovasc Res 2008, 79:269-278.
152. Mozaffari M.S., Schaffer S.W. Myocardial ischemic-reperfusion injury in a rat model of metabolic syndrome. Obesity (Silver Spring) 2008, 16:2253-2258.
153. Sin J., Puccini J.M., Huang C., Konstandin M.H., Gilbert P.E., Sussman M.A., et al. The impact of juvenile coxsackievirus infection on cardiac progenitor cells and postnatal heart development. PLoS Pathog 2014, 10:e1004249.
154. Robinson S.M., Tsueng G., Sin J., Mangale V., Rahawi S., McIntyre L.L., et al. Coxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markers. PLoS Pathog 2014, 10:e1004045.
155. Dirks-Naylor A.J. The role of autophagy in doxorubicin-induced cardiotoxicity. Life Sci 2013, 93:913-916.
156. Wang X., Wang X.L., Chen H.L., Wu D., Chen J.X., Wang X.X., et al. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK. Biochem Pharmacol 2014, 88:334-350.
157. Kawaguchi T., Takemura G., Kanamori H., Takeyama T., Watanabe T., Morishita K., et al. Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of autophagy in affected cardiomyocytes. Cardiovasc Res 2012, 96:456-465.
158. Sishi B.J., Loos B., van Rooyen J., Engelbrecht A.M. Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity. Biochem Pharmacol 2013, 85:124-134.
159. Xu X., Bucala R., Ren J. Macrophage migration inhibitory factor deficiency augments doxorubicin-induced cardiomyopathy. J Am Heart Assoc 2013, 2:e000439.
160. Li S., Wang W., Niu T., Wang H., Li B., Shao L., et al. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction. Oxid Med Cell Longev 2014, 2014:748524.
161. Gottlieb R.A., Andres A.M., Sin J., Taylor D. Untangling Autophagy Measurements: All Fluxed Up Circulation Research 2015, (in press).